News | November 13, 2023
Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
General Medicine grows 5% and Vaccines 10% led by Shingrix
The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
Lupin enters into BTA with Lupin Manufacturing Solutions
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Subscribe To Our Newsletter & Stay Updated
